stephen dilly  aimmune therapeutics inc  zoominfocom stephen george dilly  burlingame ca  intelius sign in we found stephen george dilly in burlingame ca stephen george dilly intelius found that stephen george dilly is a male between  and  years old from burlingame ca we have connected them to  addresses  phones and  relatives or associates get report now age stephen george dilly is in his s stephen has lived in burlingame ca san francisco ca stephens relatives edwina mullens lynette dilly frederick dilly mullens lynette stephen george dilly zodiac signtaurus gendermale professional status avigen  inc get report now want to know more about stephen get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about stephen or use our people search engine to find others get background check on stephen george dilly get a criminal check on stephen george dilly get a public record report on stephen george dilly get a people search report on stephen george dilly stephen george dillys contact information known cities lived in find out where stephen george dilly has lived as well as stephen george dillys phone numbers and email addresses stephen george dilly has lived in  states california address for stephen george dilly  r d burlingame ca has lived in burlingame ca san francisco ca get full address report phone numbers associated with stephen george dilly    burlingame ca    burlingame ca    san francisco ca get full phone report email addresses associated with stephen george dilly sycom get email report stephen george dillys professional information information regarding stephen george dillys professional history find out previous places stephen george dilly has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act stephen george dilly has worked at  places company avigen  inc company physic ventures title strategic advisor and member of advisory board stephen george dillys experience title company avigen  inc job details title strategic advisor and member of advisory board company physic ventures job details company size less than  mil  employee range less than  additional professional information on stephen george dilly see stephen george dillys linkedin profile stephen george dillys social network and potential email matches find out potential social network profiles and potential email usernamed for stephen george dilly stephen george dillys known social networks and potential email matches find all of stephen george dillys social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches stephen dilly username matches stephendilly dillystephen stephendilly dillystephen stephendilly dillystephen stephendilly dillystephen sdilly popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches s dilly intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here stephen george dilly sells  shares of aimmune therapeutics inc aimt stock  daily political home aboutcontact columnists privacy policy headlines politics nation world issues economy finance aimmune therapeutics inc  get news  ratings daily enter your email address below to get the latest news and analysts ratings for aimmune therapeutics inc with our free daily email newsletter follow dailypolitical     latest news quest diagnostics incorporated nysedgx stake increased by contravisory investment management inc capital management associates ny holds stake in macquarie infrastructure company mic capital management associates ny has  position in outfront media inc nyseout capital management associates ny reduces stake in t rowe price group inc trow capital management associates ny continues to hold position in carpenter technology corporation crs western new england bancorp nasdaqwneb receives “buy” rating from piper jaffray companies starbucks corporation sbux receives hold rating from wedbush the priceline group inc nasdaqpcln rating reiterated by piper jaffray companies loop capital reiterates buy rating for intel corporation intc electronic arts inc nasdaqea earns “buy” rating from wedbush lumentum holdings inc nasdaqlite position held by capital management associates ny capital management associates ny increases stake in superior energy services inc nysespn albert d mason inc has  stake in pengrowth energy corporation pgh albert d mason inc has  stake in martin midstream partners lp nasdaqmmlp apache corporation apa position lowered by albert d mason inc albert d mason inc has  position in anadarko petroleum corporation nyseapc  shares in dcp midstream partners lp dcp acquired by albert d mason inc sinovac biotech sva versus alimera sciences alim headtohead analysis carter’s nysecri vs foot locker fl critical comparison dave  buster’s entertainment play and cosi nasdaqcosi critical survey stephen george dilly sells  shares of aimmune therapeutics inc aimt stock june th    comments  filed under  by jeff wilder filed under finance  insider trades tweet aimmune therapeutics inc nasdaqaimt insider stephen george dilly sold  shares of the stock in a transaction dated friday june rd the stock was sold at an average price of  for a total transaction of  the transaction was disclosed in a document filed with the sec which is accessible through the sec website stephen george dilly also recently made the following trades on wednesday may th stephen george dilly sold  shares of aimmune therapeutics stock the stock was sold at an average price of  for a total transaction of  shares of aimmune therapeutics inc nasdaqaimt opened at  on thursday the company has a day moving average of  and a  day moving average of  the firm’s market capitalization is  billion aimmune therapeutics inc has a  week low of  and a  week high of  aimmune therapeutics nasdaqaimt last released its quarterly earnings results on monday may th the biotechnology company reported  earnings per share for the quarter topping the consensus estimate of  by  equities research analysts anticipate that aimmune therapeutics inc will post  earnings per share for the current year warning “stephen george dilly sells  shares of aimmune therapeutics inc aimt stock” was first posted by daily political and is owned by of daily political if you are viewing this report on another domain it was illegally copied and reposted in violation of us  international copyright  trademark legislation the correct version of this report can be read at httpswwwdailypoliticalcomstephengeorgedillysellssharesofaimmunetherapeuticsincaimtstockhtml hedge funds and other institutional investors have recently added to or reduced their stakes in the company swiss national bank boosted its position in aimmune therapeutics by  in the first quarter swiss national bank now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period zurcher kantonalbank zurich cantonalbank boosted its position in aimmune therapeutics by  in the first quarter zurcher kantonalbank zurich cantonalbank now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period c worldwide group holding a s purchased a new position in aimmune therapeutics during the first quarter valued at  nationwide fund advisors boosted its position in aimmune therapeutics by  in the first quarter nationwide fund advisors now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period finally columbus circle investors purchased a new position in aimmune therapeutics during the first quarter valued at  institutional investors and hedge funds own  of the company’s stock a number of equities analysts have recently commented on the stock zacks investment research upgraded shares of aimmune therapeutics from a “sell” rating to a “buy” rating and set a  price objective for the company in a research note on tuesday may th valuengine upgraded shares of aimmune therapeutics from a “sell” rating to a “hold” rating in a research note on tuesday june th finally piper jaffray companies restated an “overweight” rating and set a  price objective on shares of aimmune therapeutics in a research note on wednesday march nd one investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company aimmune therapeutics has an average rating of “buy” and a consensus price target of  aimmune therapeutics company profile aimmune therapeutics inc is a clinicalstage biopharmaceutical company developing a therapeutic approach including the development of product candidates for the treatment of peanut and other food allergies the company’s therapeutic approach which it refers to as characterized oral desensitization immunotherapy codit is a system designed to desensitize patients to food allergens using characterized biologic products defined treatment protocols and support services receive news  ratings for aimmune therapeutics inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for aimmune therapeutics inc and related companies with marketbeatcoms free daily email newsletter  comment on this post click here to cancel reply name required mail will not be published required website wordpress hashcash needs javascript to work but your browser has javascript disabled your comment will be placed in moderation latest news jeff sessions spoke of resigning after tensions increase with trump president trump’s tweets complicate already complicated week world leaders very critical of paris agreement decision by trump aide to president trump resigns with more expected scudclass missile launched by north korea  dailypolitical llc  all rights reserved privacy policy  about  columnists  contact insider trading  dilly stephen george  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  dilly stephen george select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector    directindirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   direct view gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   indirect view gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   indirect view gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   indirect view gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   direct view gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   indirect view gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   indirect view gift  pm nana aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   indirect view option award  pm na sangamo biosciences inc sgmo dilly stephen georgedirector   direct view option award  pm na aimmune therapeutics inc aimt dilly stephen georgesee remarksdirector   direct view option award  pm na sangamo biosciences inc sgmo dilly stephen georgedirector   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  stephen george dilly  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors stephen george dilly check out list of companies and businesses related to stephen george dilly find out stephen george dilly address and contact details view other people related to stephen george dilly  coworkers colleagues companions etc address co avigen inc  harbor bay pkwy alameda  ca companies related to stephen george dilly cikcompany namepositioncompany addressavigen inc dedirector  harbor bay parkway alameda sangamo therapeutics incdirector  canal blvd point richmond tech cntr richmond aimmune therapeutics incpresident and ceo  marina boulevard suite  brisbane  stephen george dilly on the web persons related to stephen george dilly  avigen inc denamepositioncitybiotechnology value fund ii lpchicagobiotechnology value fund ii lpchicagobiotechnology value fund l pchicagobiotechnology value fund l pchicagoburlingame asset management llc owner san franciscoburlingame asset management llc owner san franciscobvf acquisition llcchicagobvf incilchicagobvf incilsan franciscobvf incilchicagobvf investments llcchicagobvf investments llcchicagobvf partners l pil owner san franciscobvf partners l pil owner chicagobvf partners l pilchicagokenneth chahinechief executive officer alamedakenneth chahinechief executive officer alamedakenneth chahinechief executive officer alamedakenneth chahinechief executive officer alamedakenneth chahinedirector alamedamichael denis coffeechief business officer alamedamichael denis coffeechief business officer alamedarobert m coppedgeseattlestephen george dillydirector alamedahoward goldengreenwichhoward goldengreenwichzola p horovitzdirector alamedazola p horovitzdirector plymouth meetingzola p horovitzdirector alamedazola p horovitzdirector alamedazola p horovitzdirector alamedayuichi iwakidirector yuichi iwakidirector alamedayuichi iwakidirector alamedayuichi iwakidirector alamedayuichi iwakidirector alamedayuichi iwakidirector alamedakirk william johnsonvp research and development alamedakirk william johnsonvp preclinical development alamedamark n lampertsan franciscomark n lampertchicagodawn mcguirechief medical officer alamedadawn mcguirechief medical officer alamedaoleg nodelmansan franciscojan k ohrstromdirector alamedajan k ohrstromdirector alamedathomas j paulsonthomas j paulsonchief finance officer  secty alamedathomas j paulsonchief finance officer  secty alamedathomas j paulsonalamedamatthew d perrysan franciscoglenn piercevp research  clinical dvlpt alamedajohn k a prendergastdirector alamedajohn k a prendergastdirector alamedaandrew august sauterceo president and cfo alamedasouthpaw asset management lp owner greenwichsouthpaw credit opportunity master fund lp owner greenwichsouthpaw holdings llcgreenwichmary christina thomsonvp corp counsel  secretary alamedamary christina thomsonvp corporate counsel alamedadaniel vapnekdirector alamedadaniel vapnekdirector alamedadaniel vapnekdirector alamedarichard john wallacedirector alamedarichard john wallacedirector alamedaphilip j whitcomechairman of the board of direc alamedaphilip j whitcomechairman of the board of direc alamedaphilip j whitcomechairman of the board of direc alamedakevin wymangreenwichkevin wymangreenwichpersons related to stephen george dilly  sangamo therapeutics incnamepositioncitydale g andovp therapeutic dev  cmo south san franciscodale g andovp therapeutic dev  cmo richmonddale g andorichmonddale g andovp therapeutic dev  cmo richmonddale g andovp therapeutic dev  cmo richmonddale g andovp therapeutic dev  cmo richmonddale g andovp therapeutic dev  cmo richmonddale g andovp therapeutic dev  cmo richmonddale g andovp therapeutic dev  cmo richmondpeter blufordvp corporate development richmondrobert careydirector deerfieldcasey c casevice president research richmondcasey c casevp research  operations richmondpaul b clevelanddirector palo altopaul b clevelanddirector richmondpaul b clevelanddirector richmondedward r connersenior vp  cmo richmondstephen george dillydirector alamedastephen george dillydirector richmondstephen george dillydirector richmondwilliam g gerberdirector bothellwilliam g gerberdirector richmondwilliam g gerberdirector richmondwilliam g gerberdirector richmondwilliam g gerberdirector richmondwilliam g gerberdirector richmondphilip d gregoryvice president research  cso richmondphilip d gregorysvp of research  cso richmondphilip d gregorysvp research  cso richmondphilip d gregorysvp of research  cso richmondphilip d gregoryvice president research richmondphilip d gregoryvice president research richmondphilip d gregoryvice president research richmondphilip d gregorycso  vice president research richmondphilip d gregorysvp of research  cso richmondphilip d gregorycso  vice president research richmondcurt a herberts iiisrvp  chief business officer richmonddavid g ichikawarichmonddavid g ichikawasenior vp bus dev richmonddavid g ichikawasenior vp bus dev richmonddavid g ichikawasenior vp bus dev richmonddavid g ichikawasenior vp bus dev richmonddavid g ichikawasenior vp bus dev richmonddavid g ichikawasenior vp bus dev richmonddavid g ichikawasenior vp bus dev richmondjon e m jacobydirector little rockjon e m jacobydirector richmondroger jeffsdirector peter kolchinskybostonleroy c kopp owner edinaedward o lanphier iidirector richmondedward o lanphier iirichmondedward o lanphier iipres and chief ex officer richmondedward o lanphier iipresident  chief exec officer richmondedward o lanphier iipresident  ceo richmondedward o lanphier iirichmondedward o lanphier iipresident  ceo richmondedward o lanphier iipresident  ceo richmondedward o lanphier iipresident  ceo richmondedward o lanphier iirichmondedward o lanphier iipresident  ceo richmondedward o lanphier iipresident and ceo richmondedward o lanphier iipresident  ceo richmondedward o lanphier iipresident and ceo richmondedward o lanphier iipresident  ceo richmondedward o lanphier iipresident and ceo richmondedward o lanphier iipresident  ceo richmondedward o lanphier iirichmondedward o lanphier iipres  chief ex officer richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondjohn william larsondirector richmondmargaret liudirector richmondmargaret liudirector richmondsandy macraepresident and ceo richmondsteven j mentodirector richmondsteven j mentodirector richmondsteven j mentodirector richmondsteven j mentodirector richmondsteven j mentodirector richmondgeoffrey nicholexecutive vice president rd princetongeoffrey nicholexecutive vice president rd richmondgeoffrey nicholexecutive vice president rd richmondgeoffrey nicholexecutive vice president rd richmondh stewart parkerdirector seattleh stewart parkerdirector richmondra capital healthcare fund lpbostonra capital management llc bostonra capital management llc bostonsaira ramasastrydirector richmondsaira ramasastrydirector richmondwilliam r ringodirector william r ringodirector richmondwilliam r ringodirector richmondwilliam r ringorichmondwilliam j rutterdirector thomas g wiggansdirector richmondthomas g wiggansdirector richmondthomas g wiggansdirector richmondhenry ward wolffexec vp  cfo fremonthenry ward wolffexec vp  cfo richmondhenry ward wolffexec vp  cfo richmondhenry ward wolffexec vp  cfo richmondhenry ward wolffdirector richmondhenry ward wolffexec vp  cfo richmondhenry ward wolffexec vp  cfo richmondhenry ward wolffexec vp  cfo richmondhenry ward wolffexec vp  cfo richmondmichael c wooddirector michael c wooddirector richmondmichael c wooddirector richmondmichael c wooddirector richmondkathy yisenior vp  cfo richmondjoseph s zakrzewskidirector somersetgreg zantesr dir finance and admin richmondgreg zantesr dir finance  admin richmondgreg zantesr director finance  admin richmondgreg zantevp finance  administration richmondgreg zantevice president fin  admin richmondgreg zantevice president fin  admin richmondgreg zantevp finance  administration richmondpersons related to stephen george dilly  aimmune therapeutics incnamepositioncitydaniel c md adelmanchief medical officer south san franciscosusan e barrowcliffegeneral manager europe brisbanegregory behardirector cambridgeeric bjerkholtchief financial officer palo altowalser bryansan mateowarren l desouzachief financial officer brisbanestephen george dillypresident and ceo alamedarobert myles elfontchief medical officer brisbanepatrick g enrightdirector burlingamekathryn e falbergdirector rockvilleforesite capital fund ii lpsan franciscoforesite capital fund iii lpsan franciscoforesite capital management ii llc owner san franciscoforesite capital management iii llcsan franciscomark t iwickidirector marlboroughtananbaum jamessan franciscoanthony yun joonkyoosan mateojeffrey h knappchief operating officer fremontlongitude capital partners ii llc owner menlo parklongitude venture partners ii lpmenlo parkmark mcdadedirector nestle health science us holdings incnorwalksa nestlevevey switzerlandnimco us incnorwalkenright patrickmenlo parkhoward v raffbrisbanemary m rozenmansee remarks brisbanestacey denenberg seltzerdirector brisbanedouglas t sheehysee remarks redwood cityseltzer staceynew yorkdilly jr stephensan mateobakker juliet tammenomsmenlo parkjames b tananbaumsan franciscocolunga victorsan mateo potentially same personnamecitycountrygeorge stephenpalo altocageorge stephenpalo altocageorge stephenomahanegeorge stephenomahanegeorge stephenomahanegeorge stephenomahanegeorge stephenlos angelescageorge stephenoaklandcageorge stephenomahane microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft stephen george dilly mbbs phd executive profile  biography  bloomberg july    am et biotechnology company overview of aimmune therapeutics inc snapshotpeople  overviewboard memberscommittees executive profile stephen george dilly mbbs phdchief executive officer president and director aimmune therapeutics incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background dr stephen george dilly mbbs phd has been the chief executive officer of aimmune therapeutics inc since april  and also serves as its president dr dilly serves as strategic advisor at physic ventures llc he served as the chief executive officer of photothera inc from january  to december  and also served as its president he served as chief executive officer and president at apt pharmaceutical llc from april  to december  he has  extensive drug development experience from october  to april  he served as the senior vice president head of development and chief medical officer at chiron biopharmaceuticals in emeryville california where he was responsible for all clinical regulatory development and medicalmarketing activities worldwide prior to joining apt dr dilly held a number of senior executive clinical development and commercial support positions at leading pharmaceutical and biotechnology companies including smithkline beecham and genentech inc prior to joining chiron he served as the senior vice president of development sciences and chief medical officer and head of clinical head of development sciences vice president for clinical rd and medical affairs from  to  for genentech in south san francisco from september  to september  he was the vice president of development sciences at genentech inc from  to  dr dilly also held executive positions at central research in the united kingdom and was the vice president of cardiopulmonary and clinical neuroscience at smithkline beecham in the united states and the united kingdom he has played important roles in the development and approval of numerous drugs including kytrilr requipr kredexr paxil crr cathflor activaser raptivar xolairr avastinr lucentis cubicin and tarcevar he serves as nonexecutive chairman of the allergen research corporation inc and serves on the national board of advisors of the uc davis health system he has been a director of aimmune therapeutics inc since april  he serves as member of advisory board at bdc health venture fund he serves as a member of advisory board at physic ventures llc he has been an independent director of sangamo therapeutics inc since march   he served as a director of photothera inc he served as a director of apt pharmaceuticals inc from april  to december  he served as a director of avigen inc from february   to  in  dr dilly received an mbbs the equivalent of an md in the us from the university of london in the uk and a phd in cardiac physiology from university of london in read full background corporate headquarters  marina boulevardbrisbane california united statesphone fax  board members memberships presentindependent directorsangamo therapeutics incpresentchief executive officer president and directoraimmune therapeutics inc education phd university of londonbachelors degree university of london other affiliations avigen incgenentech incsangamo therapeutics incphotothera incuniversity of londonapt pharmaceuticals incphysic ventures llcbdc health venture fund annual compensation salarytotal annual compensation stocks options exercisable optionsexercisable options valueunexercisable optionsunexercisable options valuetotal value of optionstotal number of options total compensation total annual cash compensationtotal short term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationnamepositioncompanycompensationpierrehenri benhamou mdcofounder chairman and chief executive officerdbv technologies sakcompensation as of fiscal year  sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact aimmune therapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close secgems dilly stephen george data feeds now available excel  csv  java  python etc database learn more dilly stephen george info ownership filings ←  → ownership filings    of   total  filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer aimmune therapeutics inc aimt reporting owner dilly stephen george  director officer president and ceo  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own nonderriv transcommon stock  par values  open market or private salefalsedd nonderriv holdingcommon stock  par valueiby grat  nonderriv holdingcommon stock  par valueiby grat  nonderriv holdingcommon stock  par valueiby wifes grat  nonderriv holdingcommon stock  par valueiby wifes grat  filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo therapeutics inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer aimmune therapeutics inc aimt reporting owner dilly stephen george  director officer see remarks  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own nonderriv transcommon stock  par values  open market or private salefalsedd nonderriv holdingcommon stock  par valueiby grat  nonderriv holdingcommon stock  par valueiby grat  nonderriv holdingcommon stock  par valueiby wifes grat  nonderriv holdingcommon stock  par valueiby wifes grat  filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer aimmune therapeutics inc aimt reporting owner dilly stephen george  director officer see remarks  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own nonderriv holdingcommon stock  par valued nonderriv holdingcommon stock  par valueiby grat  nonderriv holdingcommon stock  par valueiby grat  nonderriv holdingcommon stock  par valueiby wifes grat  nonderriv holdingcommon stock  par valueiby wifes grat  derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer aimmune therapeutics inc aimt reporting owner dilly stephen george  director officer see remarks  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own nonderriv transcommon stock  par valueg  giftfalseead nonderriv transcommon stock  par valueg  giftfalseediby grat  nonderriv transcommon stock  par valueg  giftfalseeaiby wife nonderriv transcommon stock  par valueg  giftfalseediby wifes grat  nonderriv transcommon stock  par valueg  giftfalseedd nonderriv transcommon stock  par valueg  giftfalseeaiby grat  nonderriv transcommon stock  par valueg  giftfalseediby wife nonderriv transcommon stock  par valueg  giftfalseeaiby wifes grat  nonderriv transcommon stock  par values  open market or private salefalsedd nonderriv transcommon stock  par values  open market or private salefalsedd nonderriv transcommon stock  par values  open market or private salefalsedd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer aimmune therapeutics inc aimt reporting owner dilly stephen george  director officer see remarks  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own nonderriv holdingcommon stock  par valued nonderriv holdingcommon stock  par valueiby grat nonderriv holdingcommon stock  par valueiby wifes grat derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership initial statement of beneficial ownership of securities insider trading  directors officers significant shareholders  issuer aimmune therapeutics inc aimt reporting owner dilly stephen george  director officer president and ceo  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own nonderriv holdingcommon stock  par valued nonderriv holdingcommon stock  par valueiby grat nonderriv holdingcommon stock  par valueibywifes grat derriv holdingstock option right to buycommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership initial statement of beneficial ownership of securities insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer sangamo biosciences inc sgmo reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buya  grant  awardfalseacommon stockd filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer avigen inc de avgn reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transstock option right to buyd  disp to issuerfalsedcommon stock  par valued derriv transstock option right to buyd  disp to issuerfalsedcommon stock  par valued derriv transstock option right to buyd  disp to issuerfalsedcommon stock  par valued filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer avigen inc de avgn reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transnonqualified stock options right to buya  grant  awardfalseacommon stock  par valued filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer avigen inc de avgn reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transnonqualified stock options right to buya  grant  awardfalseacommon stock  par valued filing date  submission nc form  ownership initial statement of beneficial ownership of securities insider trading  directors officers significant shareholders  issuer avigen inc de avgn reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own filing date  submission nc form  ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  issuer avigen inc de avgn reporting owner dilly stephen george  director  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own derriv transnonqualified stock options right to buya  grant  awardfalseacommon stock  par valued ←  → db dilly stephen george top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active dilly stephen george • alameda ca how do i update this listing dilly stephen george is based out of alameda whalewisdom has at least  insider transactions form  in our database for dilly stephen george summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from dilly stephen george enter your email address below and choose submit your email cancel contact info dilly stephen george co avigen inc alameda ca     business phone  sec sic codebiological products no disgnostic substances recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free genentech press releases  genentech appoints dilly vice president of medical affairs search contact us about us for scientists for medical professionals for patients for media for good now hiring media  press releases attention this page may not render properly the browser you are using internet explorer  is no longer supported media inquiries   print media  press releases thursday dec   genentech appoints dilly vice president of medical affairs south san francisco calif  december    genentech inc nysegne today announced the appointment of stephen george dilly md phd to vice president medical affairs he will report to susan hellmann md mph senior vice president of development and chief medical officer dilly is responsible for genentechs medical affairs organization which includes the clinical research and safety data managementbiostatistics medical information and product experience departments stephen brings a wealth of experience and enthusiasm to this key position said hellmann with his broad experience and strong leadership i am confident that he will help maximize the clinical potential of our product candidates dilly  has held various positions with smithkline beecham pharmaceuticals since  in  he was named the director and vice president of the neurosciences therapeutic unit before that he was director and vice president of the cardiopulmonary therapeutic team group director of the department of clinical investigation group director for clinical research  development in north america director of the department of clinical investigation and senior medical adviser of the headquarters medical department prior to his work at smithkline beecham dilly was the clinical project manager of central research with pfizer inc and research fellow department of physiology at charing cross hospital medical school london dilly holds a doctorate in cardiac physiology and a medical degree from the university of london genentech inc is a leading biotechnology company that discovers develops manufactures and markets human pharmaceuticals for significant unmet medical needs twelve of the currently marketed biotechnology products stem from genentech science genentech markets seven products directly in the united states the company has headquarters in south san francisco california and is traded on the new york stock exchange and pacific exchange under the symbol gne    our pipeline our pipeline includes new molecular entities that address serious unmet medical needs approvals timeline a look at our approvals past and present feedback tell us what you think about our company products or website “ the scientist is not a person who gives the right answers he’s one who asks the right questions ” – claude lévistrauss connect with us sgmo stephen george dilly insider trades for sangamo therapeutics inc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close sangamo therapeutics inc nasdaq sgmo go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus sangamo therapeutics inc after hours  quotes are delayed by  min jul    pm sgmo quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual stephen george dilly dr stephen g dilly is president chief executive officer  director at aimmune therapeutics inc and independent director at sangamo biosciences inc he is on the board of directors at aimmune therapeutics inc and sangamo biosciences inc dr dilly was previously employed as president chief executive officer  director by photothera inc president  chief executive officer by apt pharmaceuticals inc chief medical officer  senior vice president by chiron biopharmaceuticals vpdevelopment sciences  medical affairs by genentech inc and an advisor by physic ventures llc he also served on the board at avigen inc he received his doctorate degree from the university of london and a doctorate degree from the university of london transactions date shares transaction value copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr edward o lanphier nonexecutive chairman dr alexander macrae president chief executive officer  director ms kathy yi chief financial officer  senior vice president dr michael holmes vice presidentresearch dr edward r conner chief medical officer  senior vice president dr dale g ando chief medical officer  vptherapeutic development dr mohammad a elkalay vice presidenttechnical operations dr edward j rebar vice presidenttechnology mr curt herberts chief business officer  senior vice president mr joseph s zakrzewski director dr roger a jeffs director mr robert f carey director mr bill r ringo director mr mcdavid stilwell vice presidentcommunications  investor relations ms heather erickson chief of staff ms shirley m clift vice presidentregulatory affairs ms h stewart parker independent director ms saira ramasastry independent director dr stephen george dilly independent director dr steven j mento independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aabbvie shares up  in premarket trade aabbvie still sees fullyear adj eps  to  aabbvie still sees fullyear eps  to  aabbvie q revenue  bln vs  bln factset consensus  bln aabbvie q adj eps  factset consensus  agoodyears stock plunges  premarket after q results aabbvie q eps  vs  cents agoodyear cuts  segment operating income outlook to  bln bln from  bln aget ready for the lessprofitable amazon that you used to know awells fargo charged customers for duplicate car insurance agoodyear q sales  bln vs  bln factset consensus  bln acorrect goodyear q adj eps  cents factset consensus  cents agoodyear tire  rubber q eps  cents vs  cents a year ago aamerican air shares jump  after profit beat aamerican airliness stock jumps  premarket after q results aamerican airlines to invest  bln in new aircraft in  aamerican airlines q passenger load factor  vs  a year ago aamerican airlines q prasm up  aamerican airlines q mainline passenger revenue up  to  bln aamerican airlines q  bln vs  bln factset consensus  bln loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice